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 The tumor microenvironment is characteristically acidic due to insufficient blood 
perfusion, chronic inflammation, hypoxia, and altered cell metabolism. The low pH found in the 
tumor microenvironment may facilitate the dissemination of cancer cells into the blood stream or 
lymph system by breaking down extracellular matrix components and degrading the basement 
membrane. In the murine B16F10 melanoma model, low pH has also been reported to activate 
the proton sensing G-protein coupled receptor, GPR4, and decrease cell migration in vitro as 
well as reduce pulmonary metastasis subsequent to tail vein injections. In this study we 
investigated delayed cell spreading found in B16F10 melanoma cells genetically modified to 
express GPR4 at a high level, namely B16/GPR4 cells. Attachment assays to tissue culture 
plates, fibronectin, glass coverslips, and matrigel established that B16/GPR4 cell spreading was 
significantly delayed when plated in media buffered to pH 6.4. Next, we investigated the specific 
heterotrimeric G-protein responsible for delayed B16/GPR4 cell spreading by using several 
chemical activators and inhibitors as well as numerous genetically engineered cell lines. 
Treatment with either C3-transferase (CT04), a direct Rho inhibitor, or a G12/13 inhibitory 
construct restored B16/GPR4 cell spreading significantly to a level similar to the vector control 
group and the physiological pH treatment group. We also evaluated the Gs and Gq G-protein 
 ii 
pathways by using 2’, 5’-dideoxyadenosine (DDA) and 8-bromo-cAMP or thapsigargin and a Gq 
inhibitory construct but found little modifications in B16/GPR4 cell spreading indicating the 
G12/13 G-protein pathway as the responsible variant. The downstream signaling mechanisms for 
delayed B16/GPR4 cell spreading were investigated. Both the ROCK inhibitor, Y27632, and the 
MLCK inhibitor staurosporine restored cell spreading. The same chemical inhibitors and 
activators as well as inhibitory constructs that restored B16/GPR4 cell spreading also reduced the 
formation of actin stress fibers indicating a proton-induced signaling cascade, which leads to 
increased cytoskeletal tension and delayed cell spreading.  Due to the importance of focal 
adhesion dynamics in cell spreading and migration we next investigated two focal adhesion 
proteins that are vital for this process, phospho-paxillin (Y118) and phospho-focal adhesion 
kinase (Y397). The spatial localization of phospho-paxillin (Y118) and phospho-FAK (Y397) in 
B16/GPR4 cells after one-hour attachment assays is altered when treated with acidic media, 
displaying localization to the cell body instead of the cell periphery where dynamic focal 
adhesions are located. These results indicate that a proton-induced 
GPR4/G12/13/Rho/Rock/MLCK signaling pathway is responsible for delayed melanoma cell 
spreading and altered focal adhesion dynamics. 
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Chapter 1: Introduction 
The Hallmarks of Cancer 
Cancer may be defined as a collection of diseases that is portrayed by uninhibited cell 
division and spread of malignant cells (2). To demonstrate the heavy presence of cancer in the 
United States, the expected new cases of cancer in 2012 was 1, 638,910 and the total estimated 
deaths were 577,190 (2). However, as a result of advanced biomedical research and new 
treatment options the five-year survival percentage has increased from 49% in the 1970’s to 67% 
in between 2001 and 2007 (2). Even as the survival percentage of cancer patients has increased 
since the 1970's effective treatment options for many types of cancers are still extremely rare. To 
further investigate what alternative treatment options may still exist, knowledge of the hallmarks 
of cancer may be of tremendous importance. 
In 2000, several of the known characteristics of cancer were defined in a review article 
entitled, The Hallmarks of Cancer (32). This review article speculated that cancer acquires six 
biological characteristics that contribute to the development of human tumors. The six 
characteristics that were described were self-sufficiency in growth signals, insensitivity to anti-
growth signals, limitless replicative potential, sustained angiogenesis, tissue invasion and 
metastasis, and lastly evading apoptosis (32). In addition, the same group released an updated 
version of the hallmarks of cancer in 2011 that stressed two further biological capabilities that 
contribute to the multistep development of cancer such as the deregulation of cellular energetics 
and avoiding immune destruction (31). In this report altered cellular energetics, or in other words 
altered cell metabolism, is particularly important.  
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It has been demonstrated that in the presence of oxygen tumor cells may radically shift 
away from oxidative phosphorylation to glycolysis, which is a process acknowledged as the 
Warburg Effect (87, 88, and 89) (Diagram 1). In addition, as a result of poor blood perfusion and 
inadequate tumor vasculature, an absence of oxygen may promote a further metabolic shift in 
energy production away from oxidative phosphorylation (83, 84, and 85) (Diagram 1). As a 
result of increased glycolysis in tumor cells lactate is produced. To compensate for an increased 
intracellular concentration of lactate tumor cells will export it and accumulated protons into the 
extracellular space using membrane Na
+
/H
+
 exchangers, monocarboxylate transporters, or 
carbonic anhydrases (10, 22, 29, 52, 75, and 90).
 
Proton export from the inside of the cell into the 
extracellular space will increase cell survival and permit cell proliferation (40, 51, and 90). In 
addition, proton export gradually reduces the pH of the tumor microenvironment, which causes 
extracellular acidosis (Diagram 1). This is opposite of that found in normal tissue where 
intracellular pH is more acidic than its external environment (28, 83, 84, and 85). The gradual 
lowering of extracellular pH in the tumor microenvironment over time may have many effects on 
tumor development and metastatic progression. Furthermore, how tumor cells use specific 
receptors to sense low extracellular pH and acidosis is a relatively new area of study in cancer 
research. In this study we have investigated GPR4, a receptor that senses low extracellular pH 
due to its ability to bind protons. 
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Diagram 1. The Tumor Microenvironment and Acidosis. TC-Tumor Cell. 
Malignant Transformation 
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inflammation, chemical exposure, or viral infection. Aberrant stimuli may eventually generate a 
dynamic alteration in gene expression. A modification in gene expression may lead to the 
repression of tumor suppressor genes, e.g. Tumor Protein 53, or possibly amplify the expression 
of growth signals, e.g. Epidermal Growth Factor. Modifications in gene expression promote the 
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achieving the ability to bypass normal cell death, malignant cells may begin to divide faster than 
the surrounding tissue and will eventually form a solid alien mass typically identified as a tumor.  
 The primary tumor, or the anatomical site where malignant transformation first occurred, 
begins with one cell that may have undergone one or several severe mutations. The first mutation 
that caused malignant transformation may ultimately cause further genetic anomalies and 
chromosomal instability. As the cell divides and accrues more errors in gene expression, the 
tumor cell population may evolve into a heterogeneous cell mass. This cell population will then 
evolve and the most apt for survival will be naturally selected for in a Darwinian fashion (48). 
The term that is used to describe this phenomenon is clonal evolution (27 and 48). An additional 
hypothesis is that cancer stem cells give rise to heterogeneity as a result of differentiation instead 
of error accumulation (21). Regardless of the mechanism, a diverse cell population may further 
the advancement of the tumor and may possibly lead to invasion and metastasis. The progression 
of clonal evolution is facilitated by the genetic aberrations that caused its malignancy as well as 
the extracellular environment surrounding the tumor, the tumor microenvironment. 
Tumor Microenvironment and Acidosis 
 The tumor microenvironment consists of several cell types (cancer cells and 
stromal cells), chemical signals, and extracellular matrix. There is extreme variation established 
in the tumor microenvironment in comparison to normal tissue. One important reason for this 
difference is altered tumor cell metabolism. As previously mentioned, the tumor 
microenvironment is characteristically acidic as a result of deregulated cancer cell metabolism, 
poor blood perfusion, and hypoxia (83, 84, and 85) (Diagram 1). Acidosis has been reported to 
influence gene transcription and both facilitate and inhibit metastatic progression (18 and 36). It 
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is well known that hypoxia may cause acidosis, but they may also occur independently of one 
another (18). It has been reported that acute hypoxia and acidosis may facilitate the expression of 
distinct gene sets in human mammalian epithelial cells (18). Hypoxia is reported to stimulate the 
transcription of glycolytic genes such as lactate dehydrogenase (18).  Acidosis may repress 
glycolytic gene transcription stimulated by hypoxia and kindle the activity of several genes that 
are associated with the citric acid cycle and electron transport (18).  Moreover, it has been 
determined that acidosis may also inhibit protein kinase B activity in prostate cancer, which is 
crucial for glucose uptake, cell survival, and proliferation as well as cell motility (18).  
There are several effects that acidosis may have on metastatic development. In this 
section two types of effects will be described. The first is the acute acidosis related effects and 
the second is the chronic acidosis related effects. Acute acidosis related effects have been known 
to cause cell death and the inhibition of metastatic progression (18 and 49). In a report previously 
mentioned were the specific gene sets that were activated in human mammalian epithelial cells 
following acute exposure to acidosis (18). The specific gene expression response to acute 
acidosis was then used in the same study to create a gene signature profile reflecting an acidosis 
gene expression response (18). Four breast cancer datasets were studied and next used to 
generate Kaplan-Meier survival curves (18). The gene expression response to acute acidosis in 
human breast cancers correlated with a favorable prognosis in clinical outcomes (18).  
The chronic acidosis related effects have been portrayed as a metastatic facilitator due to 
its ability to facilitate the secretion of proteases such as cathepsin B from tumor cells, which 
results in the remodeling and degradation of the extracellular matrix (63 and 90). Degradation of 
extracellular matrix proteins and the basement membrane surrounding a tumor could 
hypothetically ease the movement of migratory cancer cells through tissue and into the blood 
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stream or local lymph nodes. Furthermore, during chronic acidosis cancer cells may have the 
increased ability to adapt to acidic conditions in comparison to normal cells (49). This may 
confer a survival advantage in tumor cells and by reducing the volume of normal cells 
surrounding a tumor the area available for tumor growth increases. As you can see the 
constructive and adverse effects of acidosis on the evolution of metastatic development are 
extremely complex and have become an important aspect of study in tumor biology and 
metastasis. 
Invasion and Metastasis 
 As previously mentioned, one of the hallmarks of cancer is invasion and metastasis.  In a 
clinical setting, one of the frequent signs of solid tumor invasion and metastasis is the presence 
of cancer cells in the sentinel lymph nodes, the lymph nodes closest to the tumor itself (55). 
However, the disseminated cancer cells found in the sentinel lymph nodes are not usually 
responsible for metastasis at distant sites (16). The majority of cancer cells that seed new foci at 
distant sites will have done so through a hematogenous metastasis (16).  Hematogenous 
metastasis may occur as a result of clonal evolution and a cumulative alteration in gene 
expression. As the cell population within the primary tumor evolves, subpopulations may 
develop a migratory and invasive phenotype. To develop this phenotype, these cells may 
experience what is known as epithelial mesenchymal transition (82 and 93). Epithelial 
mesenchymal transition is a process that occurs during embryogenesis and primary tumor 
development. It is a transdifferentiation program that employs several transcription factors to 
directly, e.g. Snail, Zeb, E47, and KLF8, or indirectly, e.g. Twist, Goosecoid, E2.2, and FoxC2, 
inhibit the transcription of epithelial cadherin (6, 78, and 82). Transcription factors that stimulate 
epithelial mesenchymal transition control the expression of genes that may aid in the process of 
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cell survival, e.g. cadherin 2 (6, 78, and 82). The alteration in cell behavior that takes place 
following this process assists in the development of a migratory cell phenotype and may further 
primary tumor local, regional, and distant metastasis (78). Following the initial invasion of 
cancer cells from the primary tumor through the extracellular matrix they may be free to enter 
the blood stream and invade the body. As many primary tumor cells may enter the blood stream, 
only 0.01% of them will make it to a distant tissue and form a metastatic lesion (47).  
 The blood stream is a harsh environment for a circulating cancer cell because of host 
defenses such as the immune system and further because of its detachment from the extracellular 
matrix. The sooner a circulating cancer cell attaches to a distant tissue the better chance it may 
have for survival. Once in circulation cancer cells use a variety of ligands and receptors to attach 
to a distant surface. Known ligands used by circulating cancer cells are CD62 antigen-like family 
member E, Cadherin 2, and intracellular adhesion molecule 1 (8, 26, and 73). Similar to 
leukocytes responding to inflammation, extravasation from the blood stream into tissue has three 
distinct steps. The first step is the loose attachment of the cell to the surface of the endothelium. 
This attachment may be due to various chemical attractants; e.g. chemokine 12 attracts 
circulating cancer cells that express chemokine receptor type 4 to the bone marrow (8 and 43). 
Chemokine receptor type 4 is highly expressed in several cancers including breast, colon, and 
prostate (8 and 43). Following loose attachment, blood flow moves the cell along the surface 
giving it a characteristic rolling appearance (73). Soon after the cell has attached it would need to 
tightly adhere to the surface (73). The last two steps are cell spreading and diapedesis (73). In 
these steps the cancer cell actively spreads out and migrates into the tissue. 
Cell Spreading 
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 Cell spreading will be discussed in the following section because of its importance in the 
survival of circulating cancer cells after their attachment onto a distant tissue. Cell spreading is 
essential during normal embryonic development and physiological function. It is necessary for 
many processes such as embryogenesis, wound healing, tissue remodeling, and immune 
surveillance (60, 73, and 86). The commencement of cell attachment and spreading is 
accomplished by an initial clustering of integrins on the surface of the cell after contact with a 
suitable substrate (69) (Diagram 2). The regions where integrins cluster and the actin 
cytoskeleton is anchored to a substrate are labeled focal adhesions. Focal adhesions are sites 
where several proteins aggregate, e.g, talin, paxillin, focal adhesion kinase (FAK), etc., and 
subsequently stimulate intracellular signaling cascades that may facilitate cell survival, 
proliferation, and movement (Diagram 2). The activation of integrins following cell attachment 
to the substratum stimulates the intracellular attraction of SRC kinase to the site of clustering 
(69). The attraction of SRC kinase allows for the interaction of the SRC homology domain of 
SRC kinase with focal adhesion kinase's autophosphorylation site tyrosine 397 (53, 56, and 69). 
Focal adhesion kinase is a particularly important focal adhesion protein that contributes to 
several cell processes, e.g. cell proliferation, survival, invasion, and migration (33, 34, 53, 69, 
and 71). The activation of focal adhesion kinase leads to the subsequent activation of other focal 
adhesion proteins by SRC kinase and FAK such as P130Cas and paxillin as well as other sites 
located on focal adhesion kinase itself (53 and 69). These phospho-tyrosine residues act as 
docking sites for intracellular signaling proteins. Phospho-tyrosine residues can also stimulate 
the activity of Rho and Rac Guanine nucleotide Exchange Factors (GEFs) and GTPase 
Activating Proteins (GAPs) thus increasing or reducing their activity (45, 53, 59, 76, 77, 98 and 
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99). Consequently, an alteration in the activity of the Rho family of small GTPases may have 
numerous effects on cell morphology and function (Diagram 3). 
 
       
 
 
 
 
  
Diagram 2. Normal Cell Spreading 
 
 There are several members in the Rho family of small GTPases and their regulation is 
extremely important for cell attachment, spreading, and migration (Diagram 3). It has been well 
established that Rac activation is responsible for an accumulation of actin in the peripheral 
regions of the cell. This accumulation of actin is followed by the formation of membrane ruffles 
and lamellipodia that will aid the cell in polarization and mesenchymal-like migration (64). 
Lively regions such as membrane ruffles and the lamellipodia are composed of highly dynamic 
focal adhesions that exhibit a high turnover rate. Turnover rate refers to the time it takes to form 
and breakdown focal adhesions. The high turnover rate that focal adhesions have in these 
specific areas contributes to efficient membrane ruffling, cell spreading, and migration (57). Rac 
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activation is also vital for cell spreading due to its ability to facilitate the uncapping of 
microfilament capping proteins such as gelsolin (20). Gelsolin removal allows for actin 
polymerization that will ultimately push on the membrane to spread the cell (20). As activation 
of Rac is extremely important for cell spreading, an additional family member of the Rho family 
of small GTPases, Rho, is important for cell spreading as well. It has been established in various 
reports that aberrant activation of Rho will delay the early stages of cell spreading due to an 
increase in actomyosin contractile forces and cytoskeletal tension (5 and 86).  For example, 
during the initial stages of cell spreading, P190RhoGAP may hydrolyze Rho-GTP to Rho-GDP 
to diminish actomyosin contractile forces (5). The deactivation of Rho and reduced cytoskeletal 
tension allows rac-mediated cell spreading without hinderance from myosin activity (Diagram 
3). When Rho and Rac activation levels are not correctly regulated cell spreading will be delayed 
and membrane protrusions may be reduced. Moreover, there is a reported reciprocal relationship 
that Rho and Rac have (12).  Several studies report Rac activation as a potential indirect activator 
of numerous Rho-GAPs and the regulation of this reciprocal relationship is essential for 
determining cell morphology and rate of cell spreading (5 and 65). Lastly, cell spreading is vital 
for the survival and progression of circulating cancer cells and therefore it is a potential target in 
cancer therapy (15, 60, 68, and 98). 
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Diagram 3. The Regulation of the Rho Family of Small GTPases and their Function. 
 
 Increasing the cells contact with a substrate is important for the activation of intracellular 
signaling, which may lead to cell survival, growth, and division (33, 34, 35, 53, 69, and 71). It 
has been established that the amount of cell contact with a substrate is directly correlated with 
apoptotic index, which specifies that a reduction in surface area contact may increase apoptosis 
in cells (60). Furthermore, the adherence state of cancer cells to extracellular matrix proteins 
correlates with increased therapeutic resistance, reviewed in (92). This presents a niche for drugs 
that reduce cell spreading and subsequently allow for the sensitization towards other chemo-
therapeutic agents. Of the several cancer therapies directed at cell spreading, there are current 
studies that are directed towards cell spreading for the sensitization to TNF-related apoptosis-
inducing ligand (TRAIL) directed treatments (54). TRAIL is a molecule that is targeted for the 
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binding to TRAIL receptors induces apoptosis and by reducing cell spreading before treatment, 
its therapy has been sensitized (54). 
 In addition to TRAIL therapy sensitization there are also drugs that are aimed at receptor 
and non-receptor tyrosine kinases. Non-receptor and receptor tyrosine kinases such as focal 
adhesion kinase, SRC, and epidermal growth factor receptor have been reported overexpressed in 
several cancers (3 and 7). Cancers that are known to overexpress receptor tyrosine kinases have 
been recently targeted. Many treatments have already found their way to clinical trials and a 
select few such as Erlotinib against non-small cell lung cancer; Sutent against kidney cancer; and 
Sorafenib against solid tumors such as melanomas and carcinomas have already been marketed 
(4). Targeting over-expressed receptors that may control the rate of cancer cell spreading may 
reduce the possibility of a macrometastatic cancer growth. To be more specific, targeting focal 
adhesion kinase and SRC receptor tyrosine kinases in particular may reduce cell spreading and 
are advantageous for later stage cancer therapies (4). Cancer therapies directed toward cell 
spreading appear to be very promising and may leave a window open for sensitization towards 
many other chemical therapies. 
Cell Migration 
 In this study we investigate the dynamics of cell migration on a two-dimensional 
substrate. In vitro cell migration will be described and will be elaborated upon due to the 
correlation between in vitro cell migration and the virulence of cancer cells in vivo. Cell 
migration is a highly dynamic process that is necessary for normal embryonic development, 
immune function, and several other physiological processes. Cancer research in particular has 
placed an emphasis on the study of cell migration.  As previously mentioned, cell migration 
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plays an important role in facilitating the dissemination of cancer cells into other areas of the 
body such as the blood stream and lymph system. There are several methods of cell migration 
such as single cell migration in the case of leukocytes, fibroblasts, neuronal cells, and 
lymphocytes or group movement commonly seen for example in epithelial cells and endothelial 
cells (62).  
 In vitro, single cell migration on a two-dimensional substrate may be divided into four 
mechanically separate steps: lamellipodia extension, formation of new adhesions, cell body 
contraction, and lastly trailing edge detachment (42). Cell migration is mediated by several 
intracellular responses to extracellular cues. Filopodia are membrane protrusions that extend 
from the cell body in order to sense extracellular cues and aid the cell during migration on a two-
dimensional substrate (50). The main activator of filopodia growth is the small GTPase Cdc42 
(50). Cdc42 is a member of the Rho family of small GTPases and is reportedly activated by 
several proteins such as paxillin and P21 activated kinase 3 (11 and 50). As filopodia sense 
extracellular cues for directional migration other proteins that belong to the Rho family of small 
GTPases also do their part to insure efficient cell migration. Rac as mentioned previously is a 
member of the Rho family of small GTPases and its activation is not only crucial for cell 
spreading but cell migration as well. The uncapping of actin microfilaments by Rac activation 
permits efficient actin polymerization and treadmilling. This will also facilitate the formation of 
a large broad shaped structure at the leading edge of the cell labeled the lamellipodia. To 
efficiently migrate, the cell must form new focal contacts quickly in the leading edge of the 
lamellipodia and it must also disassemble mature focal adhesions in the rear to continue. To 
provide the leading edge with ease of movement this area has an increased rate of focal adhesion 
turnover. After polarizing, extending its leading edge, and forming new focal adhesions the cell 
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must then use actomyosin contractility to contract itself in order to move across the surface. The 
process of actomyosin contractility may be activated by Rho and subsequently the interaction 
between myosin II and actin microfilaments (86). Actomyosin contractility can be visualized 
underneath the microscope by using Rhodamine phalloidin, a fluorescence labeled toxin that 
binds to microfilaments. Actin stress fibers may be visible if this step is occurring (3). Finally, to 
complete the migration process, the trailing edge of the cell must then undergo focal adhesion 
disassembly to allow the cell to move forward (14, 30, and 72). 
G-Protein Coupled Receptors 
 G-protein coupled receptors (GPCR’s) are the largest family of cell surface membrane 
receptors (24). Humans contain over 700 different types of GPCR’s and mice use over 1000 just 
for smell (1). These receptors span the membrane seven times and specifically activate 
heterotrimeric G-proteins that may activate or inhibit several intracellular signaling pathways. 
GPCR’s have a wide variety of ligands such as peptides, hormones, lipids, photons, ions, and 
nucleotides (66). Furthermore, GPCR’s are an extremely sought after pharmaceutical target and 
half of all drugs in the market today target them (19 and 24). 
 When a ligand binds a GPCR and activates it the receptor undergoes a conformational 
change and stimulates the activity of a heterotrimeric G-protein (Diagram 4). The cytoplasmic G-
protein is attached to the plasma membrane where it connects the receptor to an enzyme or an 
ion channel. There are three protein subunits that make up a G-protein: alpha, beta, and gamma 
(1) (Diagram 4). When the receptor is inactive the alpha subunit is bound to Guanosine 
Diphosphate (GDP), but when activated, the alpha subunit will release GDP. When GDP is 
released the G-protein will alter its conformation and permit the binding of Guanosine 
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Triphosphate (GTP), which activates the alpha subunit of the G-protein and allows for it to 
disassociate from the beta and gamma subunits to perform its function (Diagram 4). There are 
four families that make up the heterotrimeric G-proteins. They are classified by the relatedness 
of the amino acid sequences in their alpha subunit (1). Discussed in this study in family one is 
the Gs pathway, in family two is the Gi pathway, in family three is the Gq pathway, and finally 
the most important pathway in this report is in family four, the G12/13 pathway (Table 1). 
 
 
  
 
 
 
 
Diagram 4. Activation of a Heterotrimeric G-protein. 
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when the Gi G-protein is activated it inhibits the activation of adenylyl cyclase (AC), therefore 
reducing cAMP levels.  
 The Gq G-protein activates phospholipase C-β (PLC-β). Activation of PLC- β leads to the 
cleavage of phosphotidylinositol 4, 5-bisphosphate into Inositol trisphosphate (IP3), which 
stimulates the release of calcium from IP3-gated calcium channels in the endoplasmic reticulum, 
and diacylglycerol (1). Diacylglycerol activates protein kinase C and translocates it from the 
cytosol to the intracellular portion of the plasma membrane where it phosphorylates a wide range 
of target proteins (1). A large increase of cytosolic calcium targets receptors such as 
Ca
2+
/calmodulin-dependent protein kinases and may lead to the phosphorylation of a number of 
regulatory proteins such as myosin light chain kinase (MLCK) (1). Calcium also accumulates in 
the mitochondria after its release into the cytosol; this accumulation has been reported to control 
the rate of energy production in the cell (38). 
 The G12/13 G-protein may be activated in response to various ligands. Its activation may 
be of particular interest when studying cell attachment, spreading, and migration. Downstream of 
G12/13 is the activation of P115 Rho-Guanine nucleotide Exchange Factor (GEF) and 
subsequently Rho, which regulates the actin cytoskeleton (39). This facilitates the exertion of 
actomyosin contractile forces and increases cytoskeletal tension (3). G12/13 G-protein downstream 
signaling pathways are investigated throughout this report and are responsible for the majority of 
the effects seen in B16/GPR4 cells following GPR4 activation. 
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Table 1. G-protein signaling pathways  
G-Protein Gs Gi Gq G12/13 
Ligands Proton, Cholic 
Acid, Dopamine 
CCL13, CXCL1 Proton, Adrenaline, 
Acetylcholine 
Proton, LPA 
Receptors  GPR4, GPBA, D1 
Receptor 
CCR1, CXCR1 GPR4, Alpha 1 
Adrenergic 
Receptor, M1 
Receptor 
GPR4, LPA 
Receptor 
Primary Response Stimulates 
Adenylyl Cyclase 
activity. 
Inhibits adenylyl 
cyclase activity. 
Stimulates PLC and 
results in the 
production of IP3 
and DAG from 
PIP2. 
Activates P115 
Rho-GEF. 
Biochemical 
Response 
Increases cAMP 
production and 
activates PKA. 
Reduces cAMP 
production. 
Stimulates Ca2+ 
release and the 
PKC pathway. 
P115 Rho-GEF 
exchanges GDP for 
GTP rendering Rho 
active. 
Biological 
Response 
Glycogen 
breakdown, bone 
resporption, water 
resorption, 
triglyceride 
breakdown, cortisol 
secretion, and 
progesterone 
secretion, etc. 
Cell proliferation, 
apoptosis, 
metabolic changes, 
etc. 
Phosphorylation 
events, gene 
transcription, 
energy production 
Actin stress fiber 
formation and cell 
anchorage. 
(cytoskeletal 
tension) 
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Proton Sensing G-Protein Coupled Receptors 
 There are a number of ligands that may bind a G-protein coupled receptor to stimulate a 
response by the heterotrimeric G-proteins (66) (Table 1). The main ligand that will be focused on 
throughout this project is the proton. The proton has been reported to activate a GPCR 
appropriately labeled the proton-sensing G-protein coupled receptor (67). Several extracellular 
histidine residues are responsible for its proton sensing abilities (67). This type of receptor can 
function in several locations throughout the body such as the kidneys, endothelial cells, lungs, 
and other regions that may require a delicate pH balance (74 and 94). When the proton sensing 
G-protein coupled receptor is stimulated by an increase in proton concentration, it elicits a proper 
response by the cell. In the family of proton-sensing G-protein coupled receptors, there are 
several members such as GPR4, TDAG8, G2A, and OGR1 (67). The only receptor that will be 
focused on in this report is GPR4 and its effects on B16F10 melanoma cell spreading and 
migration following overexpression and activation.  
 GPR4 signaling has not been fully elucidated but the results established so far have 
promise in cancer research. GPR4 has been known to activate several heterotrimeric G-proteins 
such as Gs, Gq, and G12/13 (15, 46, and 94). Previous studies with B16F10 melanoma cells that 
have been genetically engineered to express GPR4 at a high level have demonstrated that cell 
migration in vitro is inhibited at pH 6.4 and pulmonary metastasis post tail vein injections in 
mice is reduced (15). However, the effects of GPR4 overexpression on cell attachment, 
spreading, and focal adhesion dynamics have not yet been investigated. This report examines the 
G-protein signaling pathways responsible for delayed cell spreading and migration found in 
B16F10 melanoma cells genetically modified to express GPR4 at a high level, namely 
B16/GPR4 cells.
Chapter 2: Materials and Methods: 
 
Cell Lines  
 B16F10 melanoma cells were used throughout this study to characterize the effect of the 
activation of GPR4 on cell spreading and migration. All cell lines were cultured in Dulbecco’s 
Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) in a tissue 
culture incubator set at 5% CO2 and 37° C. During experimental procedures DMEM 
supplemented with 10% FBS was buffered to pH 6.4, 7.4, or 8.4 using 7.5 mM 4-(2-
Hydroxyethyl)-1-piperazineethanesulfonic acid from Fisher Scientific (Fair lawn, N.J.), 7.5 mM 
N-(2-Hydroxyethyl)-piperazine-N-N-3-propanesulfonic acid from Sigma-Aldrich (St. Louis, 
MO), and 7.5 mM 2-(4-Morpholino)-ethanesulfonic acid from Fisher Scientific (Fair lawn, N.J.), 
(known collectively as HEM). 5N Hydrochloric Acid and Sodium Hydroxide were used to buffer 
media to the desired pH. Cells grown in normal cell culture were grown to no more than 90% 
confluence, had a passage number below 10, and were 95% viable. Cells that were harvested for 
experiments were grown to no more than 70-80% confluence, had a passage number below 10, 
and were 95% viable. 
 B16/Vector and B16/GPR4 cells were previously generated by other investigators from 
Dr. Yang’s laboratory (15). B16F10/Vector cells represent a B16F10 melanoma cell line that 
was transduced with an empty vector, MSCV-IRES-GFP, as the control (15). The B16/Vector 
cells had only a minor endogenous expression level of GPR4 (Figure 1). To create the 
B16/GPR4 cell line, GPR4 cDNA was cloned into a MSCV-IRES-GFP retroviral vector as 
previously described (95), and was transduced into B16F10 melanoma cells for a stable GPR4 
overexpressing cell line as previously described (15). The resultant MSCV-huGPR4-IRES-GFP 
vector infected cells were sorted by fluorescence-activated cell-sorter for EGFP positive cells 
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(15). In addition, B16/Vector and B16/GPR4 cells were pooled and not clonal. This ruled out the 
possibility of any gene insertion-related phenomenon that could conceivably alter the results. 
The overexpression of GPR4 in B16/GPR4 cells was confirmed previously by running RT-PCR 
due to the unavailability of an antibody directed towards GPR4 (15) (Figure 1). In the RT-PCR 
35 cycles were run at an annealing temperature of 58 C (15) (Figure 1).  
 
 
 
 
The constructs, GRK-RGS PQCXIP, P115-RGS PQCXIP, and control PQCXIP used in 
this study was generated by previous lab members (95). In this report, to generate the B16/GPR4 
G12/13- and Gq- (G12/13 and Gq signaling deficient) cell lines, previously GRK2-RGS and P115 
Rho-GEF RGS constructs were subcloned into the PQCXIP retroviral vector (13, 39, and 95). 
The PQCXIP retroviral vector was then transduced into the B16/GPR4 cells using the procedure 
found in (95). B16/GPR4 cells following transduction were selected for with 2µg/mL puromycin 
for three days or until the control without resistance was completely killed. 
Tissue Culture Plate Attachment Assay 
Figure 1. RT-PCR of B16F10, B16Vector, and B16/GPR4 Cells. (A) RT-PCR 
previously completed to examine the endogenous expression of GPR4 in B16F10 
cells (15). (B) RT-PCR to confirm the overexpression of the huGPR4 construct in 
B16/GPR4 cells.  
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 Cells were detached using 0.25% Trypsin-EDTA from GIBCO® by Life 
Technologies™. Next, 5x104 cells were resuspended in DMEM supplemented with 10% FBS 
buffered to pH 6.4, 7.4, or 8.4 in a Becton Dickinson Multiwell™ 24-well tissue culture plate. 
Chemical treatments were administered at the time of cell plating. Subsequently plates were 
positioned into an incubator set at 37°C and 5% CO2 for one hour. The plates were then placed 
under the EVOS®fl Digital Inverted Microscope and 10 pictures were taken at 200X total 
magnification in various non-specific and random areas of each well (1-4 wells). Furthermore, to 
confirm cell attachment to the plate, each plate was tilted to the side to observe cell movement. 
The movement of unattached cells in media was extremely low in all treatment groups after one 
hour of incubation. In addition, the unattached cells were easily visible and were avoided when 
taking pictures. 
 To quantify the results of cell spreading, every cell in each field of view (FOV) was 
classified as round, spread, or migrating based on its morphology and then counted using Adobe 
Photoshop’s counting tool (Diagram 5). A round cell was characterized by absolutely no 
membrane protrusions, a spread cell was characterized by any cell with membrane protrusions, 
and a migrating cell was characterized by any polarized cell that represented the characteristics 
of a migrating cell, e.g. polarized, lamellipodia, and tail (Diagram 5). To acquire the percentages 
of the diverse morphological features of each cell line the number of round, spread, or migrating 
cells in each field of view was divided by the total number of cells in each field of view (30-40 
cells/FOV) (1-4 wells). The average round, spread, or migrating cell percentages were 
represented using a bar graph and tested for statistical significance using the unpaired t-test. 
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Diagram 5. Cell Attachment Assay Characterization. 
 
Matrigel Attachment Assay 
 Matrigel was thawed on ice for one hour previous to its application to tissue culture 
plates. After the matrigel was thawed, 48 µl’s of matrigel was added to each well in a Becton 
Dickinson Multiwell™ 96-well tissue culture plate and placed into the incubator set at 37° C and 
5% CO2 for 30 minutes. After the matrigel solidified into a gel, 1x10
4
 B16/Vector, B16/GPR4, 
B16/GPR4 G12/13-, B16/GPR4 Gq-, or B16/GPR4 PQCXIP cells from cell culture were plated 
onto matrigel in 2mL DMEM supplemented with 10% FBS buffered to pH 6.4, 7.4, or 8.4 and 
subsequently placed into the incubator set at 37° C and 5% CO2 for 1 hour. Plates were then 
removed and 5 pictures were taken at 200X total magnification of each well (2 Wells) using the 
EVOS®fl Digital Inverted Microscope. The same quantification method used in the tissue 
culture plate attachment assays were used to quantify the morphological features of B16F10 cells 
after attaching and spreading onto matrigel. 
Actin Staining 
 To start, 2x10
4
 cells were seeded in DMEM supplemented with 1% FBS on top of a 15 
mm round FISHER brand glass coverslip inside each well of a 24 well tissue culture plate. The 
Round Spread Spread Spread Migrating 
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cells were allowed to grow for 24 hours. The media was aspirated after 24 hours and DMEM 
without FBS was added to each well. The plates were incubated for 48 hours and the existing 
media was aspirated.  Subsequently, DMEM without FBS buffered to pH 6.4 or 7.4 was added to 
the well and the plates were incubated in a sealed chamber for 1 hour at 37° C and 5% CO2. 
Next, the media was aspirated and the wells were washed once with Dulbecco’s Phosphate-
Buffered Saline (DPBS) (GIBCO®). Cells were then fixed with a 4% paraformaldehyde solution 
for 15 minutes at room temperature and washed with DPBS. Next, 0.1% Triton-X 
permeabilization buffer (0.1% Triton-X in DPBS) was added to each well and incubated at room 
temperature for 5 minutes then washed with DPBS. A working stock solution of 100nM 
Rhodamine phalloidin in DPBS was added to each well and the tissue culture plate was wrapped 
in tin foil. It was then incubated for 30 minutes at room temperature. Following incubation, the 
media was aspirated, the well was washed three times with DPBS, and the glass coverslips were 
flipped over onto a microscope slide with one drop of VECTASHIELD® Mounting Medium for 
fluorescence with DAPI. The glass coverslip was sealed using clear nail polish and pictures were 
taken with a fluorescence microscope and a digital camera at 400X total magnification (Nikon). 
Phospho-Paxillin (Y118), Total Paxillin, and Phospho-Focal Adhesion Kinase (Y397) 
Immunocytochemistry (ICC)  
 To begin, cells were detached with 0.25% Trypsin EDTA. Next, 2.5x10
5
 cells were 
resuspended in DMEM supplemented with 10% FBS buffered to pH 6.4, 7.4, or 8.4 on a 15 mm 
round FISHER brand glass coverslip inside of a 24 well Becton Dickinson Multiwell™ tissue 
culture plate. The cells were then placed into an incubator set at 37° C and 5% CO2 for one hour 
to allow attachment. The media was aspirated and the wells washed twice with DPBS. The cells 
were fixed for 15 minutes with 4% paraformaldehyde. Following fixation, the cells were washed 
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three times with DPBS and .1% triton-X permeabilization buffer was added for four minutes and 
aspirated. Using a 1:20 dilution goat serum in PBS-T (0.1% Tween-20 in 10X DPBS), the glass 
coverslips were blocked for one hour at room temperature. The blocking solution was then 
aspirated and the primary antibody phospho-paxillin (Y118) from Cell Signaling Technology®, 
total paxillin from Santa Cruz Biotechnology Inc., or phospho-focal adhesion kinase (Y397) 
from Cell Signaling Technology® was diluted in the blocking serum 1:50 or 1:100 and added 
into each well. It was then placed on the shaker in the 4° C freezer overnight. Following 
aspiration of the primary antibody solution the secondary antibody goat anti-rabbit Rhodamine 
Red™ in goat serum + PBST at a 1:200 dilution was added to the well for one hour at room 
temperature. The secondary antibody solution was aspirated and the glass coverslips were 
washed five times. Next, the glass coverslips were flipped over onto a microscope slide with a 
drop of VECTASHIELD® Mounting Medium for fluorescence with DAPI. The glass coverslips 
were sealed with clear nail polish and observed under 1000X total magnification. To clearly 
display the data collected from the immunocytochemistry of phospho-paxillin (Y118) and 
phospho-FAK (Y397) a 3-D surface plot was created using Image-J software and further 
represented using thermal LUT imagery. Due to the unequal exposure values between samples, 
the 3-D thermal LUT surface plot is not used to compare the intensity between samples, but only 
the distribution of the signal.  
Time-Lapse Cell Culture Wound Closure Assay 
 Cells were seeded at 1x10
6
 cells per well in a Becton Dickinson Multiwell™ six well 
tissue culture plate. The cells were allowed to attach and grow to 100% confluence over a 24 
hour period in DMEM supplemented with 10% FBS. Using the tip of a pipette a wound was 
made vertically; the existing media and debris were aspirated and then washed once with DPBS. 
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Next, DMEM supplemented with 10% FBS buffered to pH 6.4, 7.4, or 8.4 was added to the well. 
The EVOS®fl Digital Inverted Microscope was used to run a 16-hour time-lapse cell culture 
wound closure assay in a controlled chamber set at 37° C and 5% CO2. Pictures were taken every 
5 minutes over a 16-hour time period at 100X total magnification to generate 193 pictures. After 
the images were saved into a file, they were imported into the Image-J program and a video was 
created. To quantify wound closure in every cell line, the cell culture wound closure assay was 
performed in 6 to13 wells of a 96 well plate. A picture was taken after the wound was initially 
made and following incubation, using a scale bar, the distance of wound closure was measured 
and divided by the number of hours incubated to get the velocity in which the wound closed. The 
average distance of wound closure is represented in a bar graph including error bars that 
represent standard error. The unpaired t-test was used to test for significance. 
 The analysis of individual B16F10 cells during the cell culture wound closure assay was 
completed by viewing the time-lapse video originally created by Image-J software. Cells that 
were clearly extending their leading edge and migrating individually were selected for viewing. 
Pictures were cropped and zoomed in to closely visualize cell migration dynamics. 
Phospho-Paxillin (Y118) and Total Paxillin Immunocytochemistry  
of Migrating B16/Vector and B16/GPR4 Cells 
 Cells were seeded at 1x10
3
 cells per well in a Thermo Fischer Scientific, Eight-Well Lab-
Tek II Chamber Slide with DMEM supplemented with 10% FBS and buffered to pH 6.4 or 7.4. 
Next, cells were incubated for 24 hours at 37° C and 5% CO2. Subsequently, the media was 
aspirated and every well was washed once with DPBS. Next, 4% paraformaldehyde was added to 
each well for cell fixation and incubated at room temperature for 10 minutes. To permeabilize 
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cells, .1% Triton-X diluted in DPBS was added to each well, incubated at room temperature for 4 
minutes, and aspirated. Each well was washed once with DPBS and aspirated. Using a 1:20 
dilution goat serum in PBS-T (0.1% Tween-20 in 1X PBS), each well was blocked for one hour 
at room temperature. The blocking solution was aspirated and the primary antibody, Phospho-
Paxillin (Y118) Rabbit mAb from Cell Signaling Technology® or total Paxillin from Santa Cruz 
Biotechnology, diluted in the blocking serum at a 1:50 or 1:100 dilution was added into each 
well. It was then placed on the shaker in the 4° C freezer overnight. Following aspiration of the 
primary antibody solution, the secondary antibody, goat anti-rabbit Rhodamine Red™ in goat 
serum + PBST at a 1:200 dilution was added to the well and incubated for one hour at room 
temperature. Next, each well was washed 5 times with DPBS and following aspiration the 
chamber separators were removed and a drop of anti-fade mounting medium with DAPI was 
placed on each well. Finally, a glass coverslip was placed on top and sealed using clear nail 
polish. Pictures were taken of cells that had a migrating morphology with a digital camera 
(Nikon) at 200X total magnification. 
Statistical Analysis 
 Statistical analysis was performed using Prism software. The unpaired t-test was used to 
test for statistical significance in the one-hour cell attachment assay and the cell culture wound 
closure assay. Error bars represent standard error in all graphs. *** P < .001, ** P < .01, * P < 
.05, ns P > .05. 
 
Chapter 3: Results 
 In the results section we describe the effects of GPR4 activation on B16/Vector and 
B16/GPR4 cell spreading, migration, and focal adhesion dynamics by using several in vitro 
assays. To begin, we investigated cell spreading using one-hour attachment assays to tissue 
culture plates, fibronectin, glass coverslips, and matrigel in DMEM supplemented with 10% FBS 
buffered to pH 6.4, 7.4, and 8.4. We then use these assays to determine potential G-protein 
pathways activated by GPR4. Furthermore, we use cell culture wound closure assays to 
investigate GPR4 overexpression during B16/Vector and B16/GPR4 cell migration. We also 
determine the rate of cell migration following the inhibition of the G12/13 G-protein signaling 
pathway. Finally, we investigate focal adhesion dynamics following GPR4 activation in 
spreading and migrating B16/Vector and B16/GPR4 cells.  In the following section, 
representative pictures of cell morphological changes will first be displayed and then the 
quantitative data will be presented. 
GPR4 Activation Delays B16/GPR4 Cell Spreading 
  Initially, throughout normal cell culture, delayed B16/GPR4 cell spreading was 
observed. Due to the significance of cell spreading in cell survival and cancer metastasis, it was 
decided to explore what was causing the delay and if it was significant. To examine B16/GPR4 
cell spreading several one-hour cell attachment assays on tissue culture plates in DMEM 
supplemented with 10% FBS buffered to pH 6.4, 7.4, and 8.4 were performed (Figure 2E-F). 
After plating B16/GPR4 and B16/Vector cells into tissue culture plates and performing one-hour 
attachment assays at pH 7.4, there was a small inhibition or delay in cell spreading (Figure 2C-
D). At pH 6.4, however, B16/GPR4 cell spreading was markedly impaired in comparison to pH 
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7.4 and 8.4 treatment groups and when compared to all B16/Vector treatment groups (Figure 
2B). 
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Figure 2. Representative Pictures of B16/Vector and B16/GPR4 Cell Spreading (A) 
and (B) B16/Vector and B16/GPR4 cell attachment and spreading at pH 6.4. (C) and (D) 
B16/Vector and B16/GPR4 cell attachment and spreading at pH 7.4. (E) and (F)  
B16/Vector and B16/GPR4  cell attachment and spreading at pH 8.4. Assay was 
repeated multiple times, e.g. Figure 3. (200X total magnification) 
A. 
C. 
E. F. 
D. 
B. 
 30 
GPR4 Activation Significantly Delays B16/GPR4 Cell Spreading 
 To quantify the difference in cell spreading following the one-hour attachment assays, 
5x10
4
 B16F10 melanoma cells were seeded into 24 well tissue culture plates with DMEM 
supplemented with 10% FBS buffered to pH 6.4, 7.4, or 8.4. Next, after one hour of incubation, 
10 pictures of each well were taken (4 wells/treatment group) at 200X total magnification. Using 
the Adobe Photoshop’s counting tool, the number of round, spread, and migrating cells were 
then counted (Diagram 5). Next, the number of round, spread, or migrating cells in each field of 
view (FOV) was divided by the total number of cells to obtain a percentage (30-40cells/FOV).  
B16/GPR4 cells at pH 6.4 exhibited 80% round cells on average compared to 33% at pH 7.4 
signifying a significant pH-dependent delay in cell spreading (Figure 3A). Furthermore, 19% of 
B16/Vector cells at pH 6.4 were round, which demonstrates a significant cell line dependent 
delay in B16/GPR4 cell spreading (Figure 3A). The B16/Vector round cell percentage was only 
slightly significant between pH 6.4 and 7.4 treatment groups, which indicate that GPR4 
activation in B16/GPR4 cells is responsible for delayed cell spreading (Figure 3A).  Lastly, the 
migrating B16/Vector cell percentage was increased 10% at pH 6.4 (Figure 3C). This may 
possibly indicate a normal migratory cell response to acidosis without overexpression of GPR4.  
 To further investigate delayed cell spreading, B16/Vector and B16/GPR4 cells were 
plated and serum starved for two days. Next, cells were treated with DMEM without FBS 
buffered to pH 6.4 or 7.4 for one hour and stained with Rhodamine phalloidin. B16/GPR4 cells 
displayed high actin stress fiber development at pH 6.4 but not at pH 7.4 (Figure 3D). In contrast 
B16/Vector cells did not form actin stress fibers (Figure 3D). This indicates increased 
cytoskeletal tension in B16/GPR4 cells, which may delay the initial stages of cell spreading. 
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Figure 3. B16/Vector and B16/GPR4 Cell Spreading and Actin Stress Fiber 
Development.  (A) Percent of round B16/Vector and B16/GPR4 cells after a one-hour 
attachment assay at pH 6.4, 7.4, or 8.4. (B) Percent of spread B16/Vector and B16/GPR4 cells 
after a one-hour attachment assay at pH 6.4, 7.4, or 8.4. (C) Percent of migrating B16/Vector 
and B16/GPR4 cells after a one-hour attachment assay at pH 6.4, 7.4, or 8.4. (D) B16/Vector 
and B16/GPR4 cell actin staining after a one hour treatment with DMEM w/o FBS buffered to 
pH 6.4 or 7.4. For quantification 10-40 fields of view (FOV) in each treatment group in A, B, 
and C was analyzed (1-4 wells). There was roughly 30-40 cells/FOV. (*** P < .001, * P < 
.05, ns P > .05) 
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B16/GPR4 Cell Spreading is Delayed on Various Substrates 
 
 B16F10 melanoma cell spreading was also examined on several substrates such as glass 
coverslips, fibronectin coated glass coverslips, and matrigel. Following a one-hour attachment 
assay the B16/GPR4 cells displayed delayed spreading on all three substrates when compared to 
B16/Vector cells at pH 6.4 (Figure 4A-F). When compared to B16/Vector cells, the majority of 
B16/GPR4 cells were round one hour after plating (Figure 4B, D, and F). Both cell lines 
displayed cell spreading similar to when plated on tissue culture plates at pH 6.4 (Figure 2A-B 
compared to Figure 4A-F). 
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Figure 4. B16/Vector and B16/GPR4 Cell Spreading on Various Substrates at pH 
6.4. (A) and (B)  B16/Vector and B16/GPR4 cell glass coverslip one-hour attachment 
assay. (C) and (D)  B16/Vector and B16/GPR4 cell fibronectin coated glass coverslip 
one-hour attachment assay. (E) and (F)  B16/Vector and B16/GPR4 cell matrigel one-
hour attachment assay. 
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GPR4 Activation Significantly Delays B16/GPR4 Cell Spreading on Matrigel 
 In previous in vivo studies, lung metastasis was reduced following tail vein injections in 
mice due to the overexpression of GPR4 in B16F10 cells (15). To investigate B16F10 cell 
attachment and spreading on alternate substrates we decided to use matrigel due to its similarity 
to lung tissue. To begin, matrigel was thawed on ice for one hour and enough matrigel was 
plated to generate a thick gel in the wells of a 96-well plate. After the matrigel solidified into a 
gel, B16F10 melanoma cells were plated on it in DMEM supplemented with 10% FBS buffered 
to pH 6.4, 7.4, or 8.4. One hour later, 5 pictures were taken of each well at 200X total 
magnification and the round, spread, and migrating cell percentages were calculated using the 
same quantification method used in the tissue culture plate attachment assays (Figure 3A-C). The 
B16/GPR4 cells behaved very much the same way and differed only slightly in round, spread, or 
migrating cell percentages. When compared to tissue culture plate attachment and spreading 
percentages, there was a small increase in the B16/GPR4 round cell percentage at pH 6.4 from 
80% to 85% and the migrating cell percentage was reduced from 3.3% to .8% (Figure 3A and 
5A). The B16/Vector cells, however, displayed a decrease in the round cell percentage from 19% 
to 14%, but also displayed a decrease in their migrating cell percentage from 29% to 18%, 
respectively (Figure 4A and 5A). Overall, the spreading of B16/GPR4 cells was substantially 
inhibited at pH 6.4 in comparison to B16/Vector cells (Figure 5A-C). Furthermore, the 
B16/Vector cells again displayed an increased percentage of migrating cells (Figure 5C). The 
similarity between the behavior of B16/GPR4 cells on matrigel, fibronectin, glass coverslips, and 
tissue culture plates signifies a substrate-independent mechanism in which cell spreading is 
delayed due to the activation of GPR4.  
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Figure 5.  B16/Vector and B16/GPR4 Cell Matrigel Attachment Assay. (A) 
Percent of round B16/Vector and B16/GPR4 cells after a one-hour attachment 
assay on matrigel at pH 6.4, 7.4, or 8.4. (B) Percent of spread B16/Vector and 
B16/GPR4 cells after a one-hour attachment assay on matrigel at pH 6.4, 7.4, or 
8.4. (C) Percent of migrating B16/Vector and B16/GPR4 cells after a one-hour 
attachment assay on matrigel at pH 6.4, 7.4, or 8.4. For quantification 10 fields of 
view (FOV) in each treatment group in A, B, and C was analyzed (2 wells). There 
was roughly 30-40 cells/FOV.  (*** P < .001, ** P < .01, * P < .05) 
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Treatment with Either C3-Transferase (CT04) or an Inhibitory G12/13 Construct 
Significantly Restores B16/GPR4 Cell Spreading and Reduces Actin Stress Fiber 
Development 
 To delineate the specific intracellular signaling pathway that is activated in B16/GPR4 
cells when GPR4 is active we first used C3-transferase (CT04).  CT04 is a cell permeable Rho 
inhibitor that reduces its activation significantly by ADP-ribosylation on Asparagine 41 of the 
effector-binding domain of Rho-GTPase. B16/GPR4 cells were treated with .75 µg/mL and 2.0 
µg/mL CT04 at the time of plating and throughout the duration of the one-hour attachment 
assays. The percentage of round cells was 51% and 36%, respectively. Both of the 
concentrations used restored B16/GPR4 cell spreading significantly. All subsequent experiments 
were completed with 2.0 µg/mL CT04 (Figure 6A). The restoration in cell spreading following 
treatment with a Rho inhibitor signifies its involvement in B16/GPR4 cell’s delayed cell 
spreading at pH 6.4. 
To further demonstrate that Rho activation may be the reason for delayed B16/GPR4 cell 
spreading at pH 6.4 we attempted to recapitulate their phenotype in the B16/Vector cells. In 
order to reveal the role that Rho activation plays during B16F10 melanoma cell spreading we 
used a commonly used indirect Rho activator, CN01, or otherwise known as Calpeptin. 
Calpeptin acts to indirectly stimulate the activation of Rho by inhibiting SH2 phosphatase, which 
normally deactivates Rho-Guanine nucleotide Exchange Factors (GEFs). Therefore, B16/Vector 
cells should potentially demonstrate a reduction in cell spreading that is comparable to 
B16/GPR4 cells at pH 6.4 if Rho activation is responsible for delayed B16/GPR4 cell spreading. 
B16/Vector cells were treated with .25 Unit/mL, .5 Unit/mL, and 1.0 Unit/mL CN01 at the time 
of plating and throughout the duration of the one-hour attachment assays. The percentage of 
A. B. 
C. 
D. 
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round cells was 42%, 67%, and 77%, respectively. All of the CN01 concentrations used inhibited 
B16/Vector cell spreading significantly but only 1.0 Unit/mL CN01 treatment is graphed in 
figure 6A. 
 Having proven that Rho activation may delay B16/GPR4 cell spreading by using 
chemical activators and inhibitors, it was decided to further connect activation of GPR4 to the 
G12/13 G-protein signaling pathway. To do this, a G12/13 inhibitory construct was transduced into 
the B16/GPR4 cells (95). By using this inhibitory construct in B16/GPR4 cells the interaction of 
the G12/13 G-protein and P115 Rho-GEF should be inhibited (39). After completing attachment 
assays at pH 6.4 we determined that when treated with media buffered to pH 6.4, B16/GPR4 
G12/13- cells demonstrated a round cell percentage that was 35% comparable to 36% in 
B16/GPR4 cells treated with CT04 at pH 6.4 (Figure 7A and 6A). The B16/GPR4 PQCXIP 
control cell line exhibited the same percentage of round cells as seen in B16/GPR4 cells at pH 
6.4 (Figure 7A). The restoration of cell spreading found in the B16/GPR4 G12/13- cells and when 
CT04 is applied to B16/GPR4 cells demonstrate that when GPR4 is activated, it activates the 
G12/13 G-protein and subsequently Rho is activated, which possibly leads to increased 
cytoskeletal tension and an alteration in cell spreading dynamics.  
 Previously, B16/GPR4 cell Rho-GTP levels were reported increased at pH 6.4 and stress 
fibers were markedly present (15). To indirectly examine the activation of Rho and the level of 
cytoskeletal tension Rhodamine phalloidin was used to stain for actin stress fibers. Following 
serum starvation and treatment with DMEM buffered to pH 6.4 for one hour actin stress fibers in 
B16/GPR4 G12/13- cells were absent. This demonstrates a reduction in Rho activation and 
cytoskeletal tension (Figure 7E). Furthermore, CT04 treatment (2.0 µg/mL) in B16/GPR4 cells at 
pH 6.4 also reduced actin stress fibers (Figure 6C). This positively demonstrates that there is a 
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correlation between G12/13/Rho activation, cytoskeletal tension, and B16/GPR4 cell spreading at 
pH 6.4. 
 In addition, to determine if the restoration in B16/GPR4 cell spreading is occurring on 
another substrate B16/GPR4 G12/13- and B16/GPR4 PQCXIP cell one-hour attachment assays 
were performed at pH 6.4, 7.4, and 8.4 on matrigel (Figure 8A). The B16/GPR412/13- cells at pH 
6.4 displayed a round cell percentage of 21% versus the 80% round cell percentage found in the 
B16/GPR4 empty vector control cell line (Figure 8A). The restoration in B16/GPR4 G12/13- cell 
spreading following attachment onto a matrigel surface continues to reveal that the B16/GPR4 
cell attachment and spreading alterations may be caused by intracellular Rho 
activation/cytoskeletal tension and not alternate substrates. 
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Figure 6. Rho Signaling in B16/Vector and B16/GPR4 Cell Spreading and Stress Fiber 
Development. (A) G12/13 pathway chemical manipulations of B16/Vector and B16/GPR4 
cells. (B) and (C) B16/GPR4 cell actin staining following 2 µg/mL CT04 treatment for 1 
hour. (D) Diagram depicting chemical activator and inhibitor effects on the G12/13 signaling 
pathway. For quantification 10-40 fields of view (FOV) in each treatment group in A was 
analyzed (1-4 wells). There was roughly 30-40 cells/FOV. (*** P < .001) 
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  Figure 7. G12/13 Signaling in B16/GPR4 Cell Spreading and Actin Stress Fiber 
Development. (A) Percent of round B16/GPR4 PQCXIP and B16/GPR4 G12/13- cells after a 
one-hour attachment assay at pH 6.4, 7.4, or 8.4. (B) Percent of spread B16/GPR4 PQCXIP 
and B16/GPR4 G12/13- cells after a one-hour attachment assay at pH 6.4, 7.4, or 8.4. (C) 
Percent of migrating B16/GPR4 PQCXIP and B16/GPR4 G12/13- cells after a one-hour 
attachment assay at pH 6.4, 7.4, or 8.4. (D) and (E) B16/GPR4 and B16/GPR4 G12/13- cell 
actin staining following 1 hour treatment with DMEM buffered to pH 6.4 and 7.4. (F) 
Diagram depicting the mechanism of action of the P115 Rho GEF RGS inhibitory construct 
in the G12/13 signaling pathway. For quantification 10-40 fields of view (FOV) in each 
treatment group in A, B, and C was analyzed (1-4 Wells). There was roughly 30-40 
cells/FOV. (*** P < .001 and ns P > .05) 
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Figure 8. G12/13 Signaling in B16/GPR4 Cell Spreading on Matrigel.  (A) 
Percent of round B16/GPR4 PQCXIP and B16/GPR4 G12/13- cells after a one-
hour attachment assay at pH 6.4, 7.4, or 8.4. (B) Percent of spread B16/GPR4 
PQCXIP and B16/GPR4 G12/13- cells after a one-hour attachment assay at pH 
6.4, 7.4, or 8.4. (C) Percent of migrating B16/GPR4 PQCXIP and B16/GPR4 
G12/13- cells after a one-hour attachment assay on matrigel at pH 6.4, 7.4, or 8.4. 
For quantification 10 fields of view (FOV) in each treatment group in A, B, and 
C was analyzed (2 Wells). There was roughly 30-40 cells/FOV. (*** P < .001 
and ns P > .05) 
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Y27632 and Staurosporine Restores B16/GPR4 Cell Spreading and Reduces Actin Stress 
Fiber Development 
 
 To further investigate downstream signaling pathways that are active following GPR4 
activation at pH 6.4, the Rho kinase (ROCK) inhibitor Y27632 was used during a one-hour 
B16/GPR4 cell attachment assay at pH 6.4. B16/GPR4 cells were treated with 1 µM, 10 µM, and 
50 µM Y27632 at pH 6.4 at the time of plating and for the duration of the one-hour attachment 
assays. The percentage of round cells was 67%, 60%, and 59%, respectively. Subsequent 
experiments were performed with 10 µM Y27632 (Figure 9A). Successive statistical analysis 
revealed that B16/GPR4 cell spreading was significantly restored (Figure 9A). Next, the kinase 
inhibitor Staurosporine (STA) was used during a one-hour attachment assay. B16/GPR4 cells 
were treated with 1.3 nM, 2.0 nM, and 4.0 nM STA at pH 6.4 at the time of plating and for the 
duration of the one-hour attachment assays. At 1.3 nM the STA product data sheet states that 
MLCK is inhibited. The percentage of round cells was 26%, 31%, and 30%, respectively. 
Subsequent experiments were performed with 1.3 nM STA (Figure 9B). Successive statistical 
analysis revealed that B16/GPR4 cell spreading was restored in all treatment groups (Figure 9B). 
This signifies that Rho may activate Rho kinase and subsequently increase MLC phosphorylation 
to increase cytoskeletal tension and delay the initial stages of B16/GPR4 cell spreading at pH 
6.4. 
 In addition, Y27632 (10µM) was used to inhibit ROCK activity in B16/GPR4 cells at pH 
6.4 for one hour before actin staining. A decrease in ROCK activity may reduce MLC 
phosphorylation by inhibiting its function of phosphorylating and deactivating MLC phosphatase 
(Figure 9F) (25 and 26). Also ROCK inactivation may reduce MLC phosphorylation by 
interrupting the potential for direct phosphorylation of MLC at serine 19 by ROCK (Figure 9F) 
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(81). The results displayed a reduction in actin stress fiber development following treatment with 
Y27632 (Figure 9D). This further correlates with an increase in B16/GPR4 cell spreading at pH 
6.4 when treated with Y27632 during a one-hour attachment assay (Figure 9A). Lastly, 
Staurosporine (1.3nM) was used to inhibit MLCK activity for one hour at pH 6.4 before actin 
staining, which may potentially decrease the phosphorylation of MLC and eventually lead to 
reduced cytoskeletal tension and stress fiber development (Figure 9F). The results were 
concordant with the hypothesis and actin stress fibers were absent following treatment with 
acidic media and Staurosporine for one hour in B16/GPR4 cells (Figure 9E). These results are 
correlative with restored B16/GPR4 cell spreading following one-hour attachment assays to 
tissue culture plates and Staurosporine treatment at pH 6.4 (Figure 9B). 
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Figure 9. Downstream G12/13 Signaling Pathways in B16/GPR4 Cell Spreading and Actin 
Stress Fiber Development. (A) Percent of round B16/GPR4 cells after a one-hour attachment 
assay at pH 6.4 and ROCK chemical manipulations. (B) Percent of round B16/GPR4 cells after a 
one-hour attachment assay at pH 6.4 and MLCK chemical manipulations. (C) (D) and (E) Actin 
staining of B16/GPR4 cells following a one hour treatment with DMEM buffered to pH 6.4 and 
10µM Y27632 or 1.3nM Staurosporine.(F) Diagram depicting the action of the kinase inhibitors 
used. For quantification 10-40 fields of view (FOV) in each treatment group in A and B was 
analyzed (1-4 Wells). There was roughly 30-40 cells/FOV. (*** P < .001) 
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The Activation/Inhibition of the Gq and Gs G-protein Signaling Pathways Does Not Affect 
B16F10 Cell Spreading on Tissue Culture Plates or Matrigel 
 To investigate other G-protein pathways that may be activated in B16/GPR4 cells when 
treated with acidic media that may potentially contribute to delayed cell spreading the Gq and Gs 
pathways were examined. To initiate our inquiry we began by simulating the activation of the Gs 
G-protein pathway in B16/Vector cells. First, 8-bromo-cAMP, a cell permeable cAMP analogue 
that is resistant to degradation was utilized. The cAMP analogue, 8-bromo-cAMP increases 
cytosolic cAMP levels and therefore the signaling pathways that are activated when the Gs 
pathway is stimulated are also activated (Figure 10C). Cells were treated with 8-bromo-cAMP at 
100 µM, 500 µM, and 750 µM concentrations at the time of plating and throughout the duration 
of the one-hour attachment assays. The percentage of round cells was 28%, 28%, and 31% 
compared to 29% round cells in the control B16/Vector sample. Successive experiments were 
carried out with 500µM 8-bromo-cAMP. Following one-hour attachment assays with 8-bromo 
cAMP (500µM) at pH 6.4, the round B16/Vector cell percentage changed from 19% to 17%, 
which was not statistically significant (Figure 10A).  
Next, 2', 5’-dideoxyadenosine (DDA), an adenylyl cyclase inhibitor, was used to inhibit 
adenylyl cylcase activity in B16/GPR4 cells at pH 6.4 (Figure 10C). A decrease in adenylyl 
cyclase activity should inhibit the signaling pathway that is used to increase cytosolic cAMP 
levels (Figure 10C). Therefore, if Gs/cAMP stimulation is involved in the delay of B16/GPR4 
cell spreading at pH 6.4, it should allow for efficient cell spreading. Cells were treated with DDA 
at 10 µM, 100 µM, and 200 µM concentrations at the time of plating and for the duration of the 
one-hour attachment assays. The percentage of round cells was 86%, 85%, and 88% compared to 
84% in the control B16/GPR4 cell sample. Successive experiments were carried out with 100µM 
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DDA (Figure 10A). The round cell percentage did not vary significantly from the B16/GPR4 cell 
control (Figure 10A). Following Gs G-protein alterations in several B16F10 melanoma cell lines, 
it was determined that the Gs signaling pathway is not responsible for the cell spreading defect 
found in B16/GPR4 cells when stimulated with acidic media. 
 The Gq signaling pathway has been previously reported active following activation of 
GPR4 (79). To examine whether the Gq pathway is involved in delayed B16/GPR4 cell 
spreading, the activation of the Gq pathway in B16/Vector cells was simulated. Following Gq 
activation and the stimulation of several signaling pathways, calcium is released from the 
endoplasmic reticulum into the cytosol of the cell and from there it affects the activity of several 
proteins (Table 1) (1). To simulate Gq pathway activation, thapsigargin, a chemical known to 
increase intracellular calcium levels was used (Figure 10C). To investigate the possibility of Gq 
involvement in B16/GPR4 cell spreading, tissue culture plate cell attachment assays were 
utilized.  B16/Vector cells were treated with 10 nM, 100 nM, and 500 nM thapsigargin at the 
time of plating and throughout the duration of the one-hour attachment assays. The percentage of 
round cells was 29%, 25%, and 27% compared to 26% in the control B16/Vector cell sample.  
Successive experiments were carried out with 500 nM thapsigargin (Figure 10B). Treatments 
with thapsigargin (500nM) during one-hour attachment assays at pH 6.4 established that there 
was no significant effect on B16/Vector cell spreading (Figure 10B).   
To further examine the role that the Gq protein may have in B16/GPR4 cells during cell 
spreading, a Gq signaling inhibitory construct was transduced into the B16/GPR4 cells. The Gq 
inhibitory construct should reduce Gq G-protein signaling through GRK2 RGS and if it is 
involved in B16/GPR4 cell spreading at pH 6.4 then cell spreading should be restored (Figure 
11D) (13). There was not a significant alteration in cell spreading at pH 6.4 in B16/GPR4 Gq- 
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cells on tissue culture plates or matrigel and they closely resembled the B16/GPR4 and 
B16/GPR4 PQCXIP cells with a round cell percentage of 79% (Figure 11A and 12A). Following 
these chemical treatments and the use of a Gq inhibitory construct, it has been determined that 
the Gq G-protein pathway is not responsible for the delayed cell spreading found in B16/GPR4 
cells at pH 6.4. 
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Figure 10. Downstream Gs and Gq Signaling in B16/Vector and B16/GPR4 Cell 
Spreading.  (A) Percent of round B16/Vector and B16/GPR4 cells after a one-hour 
attachment assay at pH 6.4 and Gs pathway chemical manipulations. (B) Percent of round 
B16/Vector and B16/GPR4 cells after a one-hour attachment assay at pH 6.4 and Gq pathway 
chemical manipulations.(C) Diagram depicting the action of drugs 500µM 8-bromo-cAMP 
(8b), 100µM DDA, or 500nM thapsigargin (TG) on the Gs or Gq signaling pathways. For 
quantification 10-40 fields of view (FOV) in each treatment group in A and B was analyzed 
(1-4 Wells). There was roughly 30-40 cells/FOV. (*** P < .001 and ns P > .05) 
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Figure 11. Gq Signaling in B16/GPR4 Cell Spreading.  (A) Percent of round B16/GPR4 Gq- 
cells after a one-hour attachment assay at pH 6.4, 7.4, or 8.4. (B) Percent of spread B16/GPR4 
Gq- cells after a one-hour attachment assay at pH 6.4, 7.4, or 8.4. (C) Percent of migrating 
B16/GPR4 Gq- cells after a one-hour attachment assay at pH 6.4, 7.4, or 8.4. (D) Diagram 
depicting the mechanism of action of the GRK2 RGS inhibitory construct in the Gq signaling 
pathway. For quantification 10-40 fields of view (FOV) in each treatment group in A, B, and 
C was analyzed (1-4 Wells). There was roughly 30-40 cells/FOV. (*** P < .001) 
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Figure 12. Gq Signaling in B16/GPR4 Cell Spreading on Matrigel (A) Percent 
of round B16/GPR4 Gq- cells after a one-hour attachment assay on matrigel at pH 
6.4, 7.4, or 8.4. (B) Percent of spread B16/GPR4 Gq- cells after a one-hour 
attachment assay on matrigel at pH 6.4, 7.4, or 8.4. (C) Percent of migrating 
B16/GPR4 Gq- cells after a one-hour attachment assay on matrigel at pH 6.4, 7.4, 
or 8.4. For quantification, 10 fields of view (FOV) in each treatment group in A, 
B, and C was analyzed (2 Wells). There was roughly 30-40 cells/FOV. (*** P < 
.001) 
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 Activation of GPR4 Alters the Localization of Phospho-Paxillin (Y118) in B16/GPR4 Cells 
during Attachment and Spreading 
 Focal adhesion dynamics are extremely important for cell spreading as well as migration. 
For efficient cell attachment, spreading, and movement, focal adhesions must undergo focal 
adhesion formation and shortly after they must be broken down in order for focal adhesion 
turnover to occur. To investigate a possible alteration in focal adhesion dynamics during 
B16/GPR4 cell spreading we inspected the phospho-protein phospho-paxillin (Y118). Several 
sources confirm that phospho-paxillin (Y118) is the first focal adhesion protein to localize to 
dynamic focal adhesions and its localization may determine where newly formed or deteriorating 
focal adhesions are situated (97). The localization of phospho-paxillin (Y118) at pH 6.4 in 
B16/GPR4 cells following one-hour attachment assays were localized to the cell body and absent 
from the cell periphery where membrane ruffling occurs (Figure 13A and 13B). Total paxillin, 
however, was localized to the cell periphery and displayed the same results in every cell line in 
each treatment group (Figure 13D). To quantify the percentage of B16/GPR4 cells displaying the 
altered phenotype after a one-hour attachment, the percentage of cells with peripheral 
localization versus cell body localization was determined by taking photos of attached cells at 
1000X total magnification of several samples. Out of 100 or more cells, single cells were 
determined to either have peripheral localization or cell body localization (Figure 13C). The 
percentage of cells with phospho-paxillin (Y118) localized to the cell body in B16/GPR4 cells 
after a one-hour attachment at pH 6.4 was 93.2% and 6.8% was localized to the cell periphery 
(Figure 13C). When treated with pH 7.4-buffered media, phospho-paxillin (Y118) is relocated 
from the cell body back to the cell periphery, which is similar to what is seen in the B16/Vector 
cells in all treatment groups (Figure 13A and 13C). The percentage of B16/GPR4 cells with 
A. 
B. 
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phospho-paxillin (Y118) localization to the cell body at pH 7.4 was 9.7% and to the cell 
periphery 90.3% (Figure 13C). In B16/Vector cells, due to highly efficient membrane ruffling 
and dynamic cell movement viewed by time-lapse photography (98), phospho-paxillin (Y118) 
signal is localized to the cell periphery at pH 6.4, 7.4, and 8.4 (Figure 13A, B, and C). Moreover, 
B16/Vector cells lacked significant phospho-paxillin (Y118) signal in the cell body, differing 
from the B16/GPR4 cells when treated with acidic media (Figure 13A). The percentage of 
B16/Vector cells displaying a phenotype similar to that of B16/GPR4 cells at pH 6.4 were slim 
with cell body localization percentages ranging from 7-9% in B16/Vector cells at pH 6.4 and pH 
7.4 (Figure 13C). The peripheral localization percentages were high ranging from 91-93% in the 
B16/Vector cells at pH 6.4 and pH 7.4, opposite of the B16/GPR4 cells at pH 6.4 (Figure 13C).  
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Activation of GPR4 Alters the Localization of Phospho-Focal Adhesion Kinase (FAK) 
(Y397) in B16/GPR4 Cells during Attachment and Spreading 
 To further investigate cell spreading during B16/GPR4 cell attachment, phospho-FAK 
(Y397) localization was explored. Focal adhesion kinase is an extremely important focal 
adhesion protein responsible for several cell processes (53). It is activated by integrin clustering 
as well as interaction of the SH2 domain of SRC kinase with focal adhesion kinase’s 
autophosphorylation site (Y397) (69). This signaling cascade leads to phosphorylation of several 
proteins including paxillin and other sites on FAK itself (53). Following one-hour B16/GPR4 
cell attachment assays at pH 6.4, the localization was similar to that of phospho-paxillin (Y118) 
in that it was localized to the cell body and absent from the peripheral regions of the cell even 
when fully spread out (Figure 14A).  At pH 6.4, 90% of the cells counted out of a total of 142 
displayed a cell body localization of phospho-FAK (Y397) (Figure 14C). At pH 7.4, however, 
out of 135 B16/GPR4 cells counted, 18.5% of them were localized to the cell body with 81.5% 
localized to the cell periphery (Figure 14C). The percent of B16/Vector cells with a localization 
of phospho-FAK (Y397) in the cell periphery ranged from 84-94% at pH 6.4 and 7.4, and the 
percent cells that had localization in the cell body ranged from 7-16% (Figure 14C). The altered 
localization of phospho-FAK (Y397) seen in B16/GPR4 cells when treated with DMEM 
buffered to pH 6.4 was not seen in B16/Vector cells.
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Figure 14. B16/Vector and B16/GPR4 Cell Phospho-Focal Adhesion Kinase (Y397) 
Immunocytochemsitry.  (A) Localization of phospho-FAK (Y397) in B16/Vector and 
B16/GPR4 cells after a one-hour attachment to glass coverslips in DMEM buffered to pH 
6.4, 7.4 or 8.4. (B) A surface plot of the emission signal using Thermal LUT, which 
displays the localization of phospho-FAK (Y397) in B16/Vector and B16/GPR4 cells. (C) 
Quantification of cell body (inside) or peripheral localization (outside) of phospho-FAK 
(Y397). Repeated 3 times. 
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Activation of GPR4 Alters Migrating Cell Morphology and Dynamics 
 
 Previously, GPR4 activation has been reported to inhibit cell migration by using cell 
culture wound closure assays and cell invasion by using transwell cell migration and invasion 
assays (15). To visualize the difference of B16/GPR4 cell migration in media buffered to pH 6.4 
and 7.4 or when compared to the B16/Vector control cells, time-lapse cell culture wound closure 
assays were performed (Figure 15A-15D). The videos that were created following time-lapse cell 
culture wound closure assays at pH 6.4 and 7.4 allowed for the visualization of B16F10 
melanoma cell migration velocity (98). The B16/Vector cells exhibited rapid migration at pH 6.4 
and 7.4 where the wound was completely closed at the 12-hour mark (Figure 15A and 15B). 
Alternatively, B16/GPR4 cell migration was inhibited at pH 6.4 and did not close after 16 hours 
(Figure 15C) (98). Furthermore, individual cell migration was studied in detail using the videos 
generated by time-lapse photography (Figure 16A and B). B16/Vector cells exhibited highly 
dynamic cell migration and movement on the surface of the well. This facilitated the efficient 
closure of the wound after 12 hours (Figure 15A).  B16/GPR4 cells, however, exhibited multiple 
defects that contributed to inhibited cell migration. In numerous B16/GPR4 cells there were 
several extensions (lamellipodia) that projected into opposing directions seemingly altering cell 
migration (Figure 16B). The trailing edge of the cell was also not able to detach generating an 
elongated trailing edge, which also inhibited cell migration (Figure 16B).   
 The inhibition of B16/GPR4 cell migration when treated with acidic media has been 
demonstrated in previous studies (15), but the restoration of migration has not yet been 
investigated. To recapitulate the migratory phenotype seen in B16/Vector cells at pH 6.4, the 
B16/GPR4 G12/13- cell line was used to test the G12/13 G-protein's involvement in reduced cell 
migration found in B16/GPR4 cells. Following quantification of B16/GPR4 G12/13- cell culture 
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wound closure assays at pH 6.4 cell migration was restored back to pH 7.4 and 8.4 treatment 
groups of B16/GPR4 cells (Figure 17A and 17B). The restoration of cell migration found in 
B16/GPR4 G12/13- cells when treated with media buffered to pH 6.4 demonstrates that activation 
of GPR4 and subsequently the G12/13 downstream pathway may be responsible for reduced cell 
migration.  
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Figure 16. Activation of GPR4 Alters Individual B16/GPR4 Cell Migration During 
Cell Culture Wound Closure Assay. (A) The phase contrast images of the migrating 
B16/Vector and (B) B16/GPR4 cells at different times (in minutes) after the wounds were 
generated (Figure 15A and C). Arrows indicate representative migrating cells and 
arrowheads indicate lamellipodia (leading edge) of migrating cells. Please note the 
divergent lamellipodia and the elongated trailing edge of B16/GPR4 cells. 
A.        B16/Vector B.         B16/GPR4 
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Figure 17. G12/13 Signaling in B16/GPR4 Cell Quantitative Snapshot Cell Culture 
Wound Closure Assays.  (A) B16/Vector and B16/GPR4 cell snapshot cell culture 
wound closure assay at pH 6.4, 7.4, and 8.4. (B) B16/GPR4 PQCXIP and B16/GPR4 
G12/13- cell snapshot cell culture wound closure assay at pH 6.4, 7.4, and 8.4. Please note 
restored B16/GPR4 cell migration at pH 6.4. Each treatment group consisted of 6-13 
repeats. (*** P < .001, ** P < .01, * P < .05, ns P > .05) 
A. B. 
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Activation of GPR4 Alters Phospho-Paxillin (Y118) Localization in Spontaneously 
Migrating B16/GPR4 Cells 
 To further investigate areas of dynamic nature, i.e. areas with a high focal adhesion 
turnover rate, in B16/GPR4 cells at pH 6.4 we investigated phospho-paxillin (Y118) localization 
in spontaneously migrating cells. It was previously demonstrated that the localization of 
phospho-paxillin (Y118) and phopho-FAK (Y397) is altered in B16/GPR4 cells during 
attachment and spreading at pH 6.4 (Figure 13 and 17). Moreover, following cell culture wound 
closure assays it was also established that the B16/GPR4 cells were having trouble migrating 
partially due to delayed trailing edge detachment (Figure 15) (98). To determine what 
mechanism is reducing trailing edge detachment in B16/GPR4 cells phospho-paxillin (Y118) 
localization was investigated due to its ability to localize to newly formed and deteriorating focal 
adhesions. Next, immunocytochemistry of phospho-paxillin (Y118) was performed and cells that 
were spontaneously migrating were selected for photographs. Pictures were taken at 100X, 
200X, and 1000X total magnification of several B16/Vector and B16/GPR4 cell samples. The 
results demonstrated that there was an alteration in the localization of phospho-paxillin (Y118) in 
migrating B16/GPR4 cells when treated with DMEM buffered to pH 6.4. The leading edge of the 
B16/Vector cells demonstrated an accumulation of phospho-paxillin (Y118) as well as an 
accumulation in the trailing edge region where detachment occurs (Figure 18A). In B16/Vector 
cells, 87% of the cells counted localized phospho-paxillin (Y118) to the leading edge and trailing 
edge region and 13% was missing its accumulation at the leading edge or trailing edge region 
(Figure 18B). B16/GPR4 cells, however, had a reduction in the accumulation of phospho-
paxillin (Y118) (12%) at the leading edge and at the trailing edge region (Figure 18B). This 
indicates that there may be an absence of dynamic focal adhesions in these regions when GPR4 
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is active. The absence of newly formed or breaking down focal adhesions at these sites may 
impair B16/GPR4 cell migration due to the aberrant maturation of focal adhesions and reduced 
focal adhesion turnover. 
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Figure 18. Migrating B16/Vector and 
B16/GPR4 Cell Phospho-Paxillin (Y118) and 
Total Paxillin Immunocytochemistry. (A) 
Migrating B16/Vector and B16/GPR4 cell total 
paxillin and phospho-paxillin (Y118) ICC at pH 
6.4 and 7.4. Please note the white arrows pointing 
to normal transient focal adhesions in the leading 
edge and trailing edge region and red arrows 
pointing to the lack of transient focal adhesions in 
these areas. The lack of transient focal adhesions 
in the trailing edge region most likely contributes 
to a characteristic elongated trailing edge in 
B16/GPR4 cells (Figure 16B). (B) Migrating 
B16/Vector and B16/GPR4 cell phospho-paxillin 
(Y118) quantitative ICC. Repeated 2 times. 
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Chapter 4: Discussion 
 In this study we examined the effects of GPR4 activation on B16F10 melanoma cell 
attachment, spreading, and migration. In addition, we explored the potential molecular 
mechanism that may be the foundation for reduced metastatic potential found previously in 
B16/GPR4 cells (15). Several reports provide evidence for acidic environments to either enhance 
or reduce the migration and metastatic capabilities of tumor cells (15, 31, 58, and 61). The 
migration and invasive ability of B16/GPR4 cells has been studied previously, but delayed cell 
spreading was not investigated. The signaling mechanisms that delay cell spreading following 
GPR4 activation in B16/GPR4 melanoma cells may further explain the effects of an acidic 
microenvironment on primary tumor cells. Furthermore, the importance of cell spreading in 
circulating cancer cell survival is high and by activating the G12/13 G-protein signaling pathways 
possibly with chemicals that were used in this study (CN01) or by introducing the GPR4 
construct to a primary tumor site we may add to the numerous therapeutic strategies used to treat 
cancer (54 and 68).  
 At acidic pH, the attachment and spreading of B16F10 melanoma cells that express 
GPR4 at a high level is delayed in comparison to the vector control B16 cells when plated on 
several substrates (Figures 2 and 3). Viewed by time-lapse attachment assays in vitro, the 
dynamic movements typically found in B16F10 melanoma cells has been lost following the 
aberrant expression of GPR4 (98). This may also correlate with previous results that report 
reduced B16/GPR4 cell pulmonary metastasis in mice post tail vein injections (15). Moreover, 
the reduction in membrane protrusions in B16/GPR4 cells during attachment and spreading and 
while suspended may also further verify the report that increased micro-metastatic outgrowth 
may be facilitated by filopodia-like structures (68 and 98). We also demonstrate that activation 
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of GPR4 is coupled to the G12/13 G-protein and that its activity possibly delays cell spreading and 
further reduces the number of membrane protrusions because of increased cytoskeletal tension 
and membrane rigidity.  
 Established in several reports, cytoskeletal tension must be relieved during the initial 
phase of cell spreading (5 and 86). Furthermore, cell spreading is reportedly inversely correlated 
with myosin activity (5 and 86). The small molecule Rho is partially responsible for facilitating 
myosin activity and is downstream from the G12/13 G-protein (39). This is particularly relevant to 
this study due to previous results that demonstrate an increase in Rho activation in B16/GPR4 
cells when compared to B16/Vector cells at pH 6.4 (15). The increased activity of Rho also 
correlated with increased actin stress fiber development in B16/GPR4 cells when serum starved 
and treated with media buffered to pH 6.4 (15). Furthermore, when B16/GPR4 G12/13- cells are 
serum starved and treated with media buffered to pH 6.4 actin stress fiber development is absent 
(Figure 7E). This correlates with restored cell spreading following a one-hour attachment assay 
(Figure 7A). To further examine delayed B16/GPR4 cell spreading CT04 was used to inhibit 
Rho activation during a one-hour attachment assay. The inhibition of Rho with CT04 in 
B16/GPR4 cells restored cell spreading, which indicates Rho’s involvement in B16/GPR4 cell 
spreading (Figure 6A).  Increased intensity of Rho-mediated actomyosin contractility has been 
demonstrated in several reports to reduce membrane protrusions and delay cell spreading and 
migration (5 and 23). This hypothesis may potentially explain why B16/GPR4 cell spreading is 
delayed at pH 6.4.  
 Downstream of Rho activation is the activation of the Rho kinase (ROCK). Rho and 
ROCK has been reported to phosphorylate the MBS site of MLC-phosphatase, which leads to its 
deactivation (25 and 37). Inactivation of MLC-phosphatase by ROCK increases the relative 
 67 
phosphorylation of MLC indirectly. ROCK has also been reported to phosphorylate MLC 
directly in vitro, which increases cytoskeletal tension and may produce actin stress fibers that are 
similar to B16/GPR4 cells at pH 6.4 (Figure 3D) (81). Next, the hypothesis that Rho activation 
may increase ROCK activation and subsequently stimulate MLC phosphorylation in B16/GPR4 
cells was investigated. During a one-hour attachment assay at pH 6.4 B16/GPR4 cells were 
treated with Y27632 and its function restored their ability to spread (Figure 9A). What's more, 
following serum starvation for two days and cytoskeletal staining using Rhodamine phalloidin 
actin stress fibers were absent in B16/GPR4 cells at pH 6.4 when treated with Y27632 (Figure 
9D). To examine the possible effects of reduced myosin light chain (MLC) phosphorylation on 
the ability of B16/GPR4 cells to spread, staurosporine (STA) was used to inhibit myosin light 
chain kinase (MLCK) activity during a one-hour attachment assay. Following the inhibition of 
MLCK by STA, B16/GPR4 cell spreading was restored (Figure 9B). Moreover, after serum 
starvation for two days and treatment with STA for one hour at pH 6.4 actin stress fibers were 
absent (Figure 9E). These results support the premise that GPR4/G12/13/RHO/ROCK activation 
may directly or indirectly activate MLC and lead to increased cytoskeletal tension and delayed 
B16/GPR4 cell spreading at pH 6.4.  
 B16/Vector and B16/GPR4 cell spreading and the G-protein signaling pathways 
responsible for the effects at acidic pH were investigated thoroughly in this report but as with 
any study there were limitations. To begin, there was no direct observation that round B16/GPR4 
cells had increased myosin contractility at pH 6.4; only that actin stress fiber development was 
present in the same conditions while cells were spread on a surface (Figure 3D). In addition, the 
activation of G12/13 was never measured directly but was assumed active due to the restoration in 
B16/GPR4 cell spreading following the application of a G12/13 inhibitory construct (Figure 7A). 
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Furthermore, the activity of Rho, cAMP levels, ROCK activity, MLCK activity, and cytosolic 
calcium levels were never directly measured following the use of chemicals that were 
theoretically believed to lead to the manipulation of these pathways, e.g. CT04, CN01, 8-bromo-
cAMP, DDA, Y27632, staurosporine, and thapsigargin. As for the G12/13 and Gq G-protein 
pathways, the inhibitory constructs that were used made up for this limitation. However, the Gs 
pathway was not inhibited with a transduced construct, which was a limitation in the 
investigation of Gs signaling.  
 GPR4 signaling that leads to delayed cell spreading has been discussed and the potential 
mechanism responsible for these effects has potentially been unveiled. Although the mechanism 
following activation may have been indirectly uncovered, the effects on focal adhesion formation 
and cell migration have not yet been examined in detail. In several reports phospho-paxillin 
(Y118) has been demonstrated to localize to dynamic focal adhesions (5, 91, and 97). The 
localization of phospho-FAK (Y397) may also represent dynamic focal adhesions. When it is 
present at regions of integrin clustering it may recruit SRC and may allow for focal adhesion 
turnover. Several reports cite the presence of SRC may facilitate the degradation of focal 
adhesions (30 and 91).  Furthermore, focal adhesion turnover also occurs through the calcium 
dependent protease calpain (14, 30, and 72). Calpain’s interaction with FAK is required for the 
calpain-mediated disassembly of focal adhesions, which may increase focal adhesion turnover 
(14 and 30). Dynamic focal adhesions have a high turnover rate and are in the continuous 
process of either being assembled or disassembled. Cells that contain a high number of transient 
focal adhesions may also migrate and spread faster. Alternatively, mature focal adhesions lack 
(Y118) phosphorylated paxillin and exhibit reduced turnover rates, which may reduce membrane 
ruffling and cell migration (5, 91, and 97). To investigate the localization of dynamic adhesions 
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in B16/GPR4 cells at pH 6.4 during cell spreading, cells were immuno-stained with a phospho-
paxillin (Y118) or phospho-FAK (Y397) antibody after a one-hour attachment assay on glass 
coverslips. The results reveal an alteration in the localization of phospho-paxillin (Y118) and 
phospho-FAK (Y397) from the cell periphery to the cell center (Figure 13 and 17). The altered 
localization of dynamic focal adhesions from the B16/GPR4 cell periphery to the center 
correlates with the reduction in membrane ruffling previously viewed by time-lapse photography 
(98). The G12/13/Rho/ROCK/MLC mechanism influencing cell spreading discussed previously 
may also be correlated with these changes (Diagram 6). ROCK activation in several studies has 
been reported to alter the localization of focal adhesions to the cell center from the cell periphery 
and may also encourage an amoeboid like morphology (62, 80, and 81). Furthermore, 
constitutively active MLC due to inhibited MLC phosphatase activity can also lead to inhibited 
migration because of reduced focal adhesion turnover and focal adhesion maturation (80). As the 
localization of dynamic focal adhesions is altered in B16/GPR4 cells at pH 6.4 total paxillin was 
not altered and did not show any variation when compared to pH 7.4 or B16/Vector cells (Figure 
13). This indicates that stable focal adhesions were present but dynamic focal adhesions were 
absent in areas that permit efficient membrane ruffling.  
 Following the investigation of B16/GPR4 cell spreading and focal adhesion dynamics at 
pH 6.4, cell migration was examined next. In previous studies B16/GPR4 cell migration in vitro 
was inhibited (15). In this study time-lapse and quantitative cell culture wound closure assays 
were used to examine the morphological characteristics and velocity of migrating B16F10 cells. 
B16/GPR4 cell migration appeared to be inhibited at pH 6.4 and also exhibited an elongated 
trailing edge due to an inability to detach (Figure 15C, 16B, and 17A) (98). To investigate the 
signaling pathways that may lead to inhibited B16/GPR4 cell migration at pH 6.4 B16/GPR4 
 70 
G12/13- and B16/GPR4 PQCXIP cells were used in cell culture wound closure assays (Figure 
17B). Following quantification of B16/GPR4 G12/13- cell wound closure there was a significant 
rescue of cell migration (Figure 17B). Furthermore, cell migration does not seem to fluctuate as 
it did before when exposed to media buffered to pH 6.4, 7.4, or 8.4 (Figure 17B). This validates 
that GPR4 signaling through the G12/13 G-protein signaling pathway inhibits B16/GPR4 cell 
migration (Figure 17B). 
 As we studied the activation of GPR4 in B16/GPR4 cells and found that cell migration 
was reduced at acidic pH, we also found other effects of acidosis on B16/Vector cell migration. 
In Figure 2A, 3C, 5C, 15A, and 17A the B16/Vector cell migration velocity and the migrating 
cell percentage was increased at pH 6.4. When comparing B16/Vector cells with B16/GPR4 cells 
at pH 6.4 the effects on cell migration seem to be the opposite. The migration velocity and 
migrating B16/GPR4 cell percentages were reduced at pH 6.4. As the expression level of GPR4 
in B16/Vector cells are relatively low, this may represent the response of a cell without proton-
sensing G-protein coupled receptor expression to acidosis. In one known report OGR1 
overexpression was reduced in distant metastasis in comparison to the primary tumor site, which 
may imply that the proton-sensing G-protein coupled receptors may function as metastasis 
suppressor genes (41 and 70). 
 Discussed in detail previously was focal adhesion dynamics during B16F10 cell 
spreading. After accepting that there was an alteration in the localization of dynamic focal 
adhesions during B16/GPR4 cell spreading when treated with media buffered to pH 6.4 we 
hypothesized that there was a potential connection between altered focal adhesion dynamics and 
inhibited B16/GPR4 cell migration. To test this hypothesis we immuno-stained B16/GPR4 cells 
with phospho-paxillin (Y118) and total paxillin twenty-four hours after plating to permit efficient 
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time for cell spreading and spontaneous migration. The results demonstrate that not only was 
there an alteration in focal adhesion dynamics during B16/GPR4 cell spreading at pH 6.4 but the 
localization of dynamic focal adhesions in migrating cells were altered as well (Figure 18A). In 
normal migrating cells dynamic focal adhesions are localized to the leading edge and the trailing 
edge of the cell to allow for efficient migration. On the other hand, in the event that dynamic 
focal adhesions are not localized to these regions cell migration may be disrupted. The dynamic 
focal adhesion localization in B16/GPR4 cells when treated with media buffered to pH 6.4 
seemed to be throughout the cell in unusual regions that they are not normally found (Figure 
18A). There was also an absence of dynamic focal adhesions in the leading edge as well as the 
trailing edge region, which potentially explains reduced trailing edge detachment, previously 
viewed in time-lapse cell culture wound closure videos (Figure 18A-B) (98). Various reports 
indicate that constitutively active MLC may lead to the stabilization of focal adhesions and may 
also block cell migration, which is also true of Rho and ROCK (17 and 80). As discussed 
previously paxillin is localized in mature focal adhesions. In spontaneously migrating B16/GPR4 
cells paxillin is present in dynamic regions such as the leading edge and trailing edge but 
phospho-paxillin (Y118) is not (Figure 18). This demonstrates the absence of transient focal 
adhesions but presence of mature focal adhesions in B16/GPR4 cells at pH 6.4. The alteration of 
focal adhesion dynamics in B16/GPR4 cells may be potentially connected to a 
GPR4/G12/13/Rho/ROCK/MLC signaling pathway (Diagram 6) that when constitutively active 
will lead to the aberrant maturation of focal adhesions, which could lessen cell migration. 
 The results that were obtained in this study have promise for future investigation of 
GPR4 or other proton sensing G-protein coupled receptors in the process of tumor cell invasion 
and metastasis. Following the overexpression of GPR4 in B16F10 melanoma cells cell spreading 
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was delayed and their normal dynamic nature was lost potentially due to increased cytoskeletal 
tension and membrane rigidity. Reducing membrane protrusions and losing the dynamic nature 
of the cell membrane may reduce the chances for a tumor cell to invade tissue and enter the 
blood stream (68). It may also diminish the possibility of circulating cancer cells to attach and 
invade a distant tissue. Previously unknown data about GPR4 signaling has also been uncovered 
such as GPR4 signaling specifically through G12/13, Rho, ROCK, and MLC pathway (Diagram 6) 
to increase cytoskeletal tension. In addition, GPR4 signaling may also alter focal adhesion 
dynamics. G12/13 signaling potentially explains several of the effects seen in B16/GPR4 cells 
following the stimulation of GPR4 by acidic media. Furthermore, as focal adhesion dynamics, 
cell spreading, and cell migration are important for a broad range of physiological processes the 
alteration in cell dynamics following GPR4 activation may have future potential in various fields 
of research.  
 The potential implications for this study may be advantageous in the management of 
tumor metastasis as this field is in need of new treatment options. There may be an avenue for 
chemical therapy that exists based on targeting certain aspects of the tumor microenvironment. In 
particular acidosis may be used to target drug release to reduce the systemic effects commonly 
observed when utilizing chemical therapy to treat cancer (44 and 99). Furthermore, gene therapy 
that commonly detects unwanted systemic toxicity may be used with further efficacy with 
approaches that target tumor acidosis (44 and 99). Several reports have investigated the potential 
to target drugs to the acidic microenvironment. One such method established that by using 
polyethylene glycol (PEG)-based hydrogels integrated with Imidazole that drug release 
(Antagomir) was enhanced in acidic environments (44). Imidazole is a heterocyclic organic 
compound that may accept protons and allows for increased water solubility and enhanced 
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degradation of PEG-based hydrogels (44). As Antagomir may be released efficiently in acidic 
environments, additional efficacious materials that induce anti metastatic responses may be used 
as well. For example, introducing plasmid DNA, such as the MSCV-huGPR4-IRES-GFP vector 
used in this study, into PEG-based hydrogels may potentially be developed in the future. 
Equivalent to targeting acidosis in the tumor microenvironment by using PEG-based hydrogels is 
incorporating chemical drugs in liposomes that are degraded through acid sensitive mechanisms 
(99). Moreover, a drug or antibody carried by nanoparticles that may potentiate GPR4 activation 
may induce a response in tumor cells that is similar to this report for example: delayed cell 
spreading, inhibited migration, and altered focal adhesion dynamics. The therapeutic 
implications for tumor cell response to the acidic microenvironment by the proton sensing G-
protein coupled receptors seem ample as there is a broad range of potential therapeutic 
discoveries still to be established in this family. 
 In conclusion, the implications for cancer therapy have been discussed but relevance of 
the proton sensing G-protein coupled receptors in normal cells is still not been completely 
understood. It is most likely highly expressed in the areas of the human body that need a delicate 
pH balance, e.g. kidney, lung, or other tissue that regulates acid-base balance. Furthermore, there 
is little known about the expression levels of the proton sensing G-protein coupled receptors 
throughout the extremely large variety of human cancers. Unpublished data in Dr. Yang's lab has 
uncovered a higher expression of these receptors in hematological malignancies such as 
leukemia and lymphomas. This relatively unexplored family of proton sensing G-protein coupled 
receptors is an extremely new aspect of study in cancer research and in normal physiological 
function. The avenues for research on this topic are ever-expanding and may even further our 
general knowledge of cell biology and human disease.  
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